Celecoxib Colorectal Bioavailability and Chemopreventive Response in Patients with Familial Adenomatous Polyposis
Why celecoxib exerts chemopreventive activity in only some familial adenomatous polyposis (FAP) patients remains poorly understood. We conducted a phase II clinical study to identify potential predictive biomarkers for celecoxib chemopreventive activity in FAP. Twenty-seven patients with FAP complet...
Main Authors: | Advani, S. (Author), Day, R.S (Author), Malek, J. (Author), Shureiqi, I. (Author), Wei, B. (Author), Yang, P. (Author), Zuo, X. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
NLM (Medline)
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Children’s International Polyposis (CHIP) study: a randomized, double-blind, placebo-controlled study of celecoxib in children with familial adenomatous polyposis
by: Burke CA, et al.
Published: (2017-07-01) -
Familial adenomatous polyposis, diagnosis and
surveillance strategies: review article
by: Sima Sedighi, et al.
Published: (2020-10-01) -
AXIN2-Associated Adenomatous Colorectal Polyposis
by: Bruno Augusto Alves Martins, et al.
Published: (2021-08-01) -
Germline mutation at codon 1309 of the adenomatous polyposis coli gene and exteracolonic manifestations in familial adenomatous polyposis
by: Faegheh Behboudi Farahbakhsh, et al.
Published: (2017-07-01) -
Mutations in the adenomatous polyposis coli (APC) gene in patients with familial adenomatous polyposis (FAP) with congenital hypertrophy of the retinal pigment epithelium (CHRPE).
Published: (1998)